2019
DOI: 10.1021/acsami.8b21398
|View full text |Cite
|
Sign up to set email alerts
|

Lipid-mRNA Nanoparticle Designed to Enhance Intracellular Delivery Mediated by Shock Waves

Abstract: Cellular membranes are, in general, impermeable to macromolecules (herein referred to as macrodrugs, e.g., recombinant protein, expression plasmids, or mRNA), which is a major barrier for clinical translation of macrodrug-based therapies. Encapsulation of macromolecules in lipid nanoparticles (LNPs) can protect the therapeutic agent during transport through the body and facilitate the intracellular delivery via a fusion-based pathway. Furthermore, designing LNPs responsive to stimuli can make their delivery mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
43
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(43 citation statements)
references
References 43 publications
0
43
0
Order By: Relevance
“…DNA in the form of a circular plasmid or messenger RNA (mRNA), which are longer than RNAi molecules, can also be loaded into nanocarriers to effectively express a protein in a target cell. [73][74][75][76] Moffett et al and Smith et al each developed a nanocarrier that specifically targets the T cells of patients and delivers mRNA or a DNA plasmid into the T cells to transform them into chimeric antigen receptor (CAR) T cells in situ or ex vivo. [77,78] In this nanocarrier, mRNA or a DNA plasmid encoding the CAR is condensed by incubation with poly(beta-amino ester) (PBAE) 447 polymer and a polyglutamic acid-antibody recognizing cluster of differentiation 3 (CD3), a protein found on the surface of T cells.…”
Section: Nucleic Acids As Therapeutics Using Nanocarriersmentioning
confidence: 99%
“…DNA in the form of a circular plasmid or messenger RNA (mRNA), which are longer than RNAi molecules, can also be loaded into nanocarriers to effectively express a protein in a target cell. [73][74][75][76] Moffett et al and Smith et al each developed a nanocarrier that specifically targets the T cells of patients and delivers mRNA or a DNA plasmid into the T cells to transform them into chimeric antigen receptor (CAR) T cells in situ or ex vivo. [77,78] In this nanocarrier, mRNA or a DNA plasmid encoding the CAR is condensed by incubation with poly(beta-amino ester) (PBAE) 447 polymer and a polyglutamic acid-antibody recognizing cluster of differentiation 3 (CD3), a protein found on the surface of T cells.…”
Section: Nucleic Acids As Therapeutics Using Nanocarriersmentioning
confidence: 99%
“…Confocal laser scanning microscopy (CLSM) and TEM were used to investigate the intracellular transport of lipoplexes [20,21]. Hoechst 33342, NBD-PE and Cy5-DNA were used here in order to detect the intracellular distribution of liposome/DNA lipoplexes.…”
Section: Cellular Uptake and Dna Release Using Clsmmentioning
confidence: 99%
“…Cavitation is the formation of vapor cavities in a liquid due to a tensile stress (1) and is assumed to be one of the key mechanisms for biophysical effects of ultrasound and in particular shock waves (2,3). It has been suggested as a possible mechanism both in transmembrane and intracellular drug delivery (4) as well as acoustic excitation of the peripheral nervous system (5). The key biophysical system in both these cases is the cellular membrane, which is essentially a self-assembled macromolecular bilayer mainly composed of lipids.…”
Section: Introductionmentioning
confidence: 99%